Ethical considerations attend decisions about disclosing a likely dementia diagnosis. They begin with patient autonomy – a core value of medicine.
Read MoreSuicide Risk and Prevention in Epilepsy: Expert Insights from Dr. Tatiana Falcone
From increased risks to effective screening approaches, special pediatric considerations and the role of medications, our expert shares insights on the intersection of seizures and suicidality.
Working with Transgender Adolescents: A Primer for Psychiatrists
Child and adolescent psychiatrists are increasingly asked to work with transgender youth, but many have no training with this patient population. An expert shares his approach.
Wondering How to Offer Brexanolone for Postpartum Depression? Here’s How We’re Piloting It
This novel infusion therapy could be a breakthrough for postpartum depression, but its administration is complex and highly regulated. Three psychiatrists outline how we’ll introduce it in our health system.
The Essentials on Esketamine for Treatment-Resistant Depression
The newly approved intranasal ketamine derivative helps fill clear gaps in short-term therapy, says one expert, but questions remain around its long-term effects and affordability.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Advice on Creating a Healthcare Safe Haven for LGBTQ Youth
Making clear that your practice is a safe space for LGBTQ youth is a huge first step toward easing the anxieties of teens needing care as they struggle with sexual identity issues.
When Bariatric Surgery Comes Up Short: Probing the Behavioral-Biological Reasons
Cleveland Clinic is co-directing a newly launched NIH clinical trial that aims to better understand — and potentially target — the mind and body factors behind suboptimal bariatric surgery outcomes.
Ketamine vs. ECT: $11.8M Grant Helps Size Them Up for Treatment-Resistant Depression
Ketamine has emerged as an alternative to electroconvulsive therapy for treatment-resistant depression, but no study has compared the two. A major research project led by Cleveland Clinic is changing that.
Deep Brain Stimulation for Neuropsych Disorders: Don’t Count It Out Yet
An expert panel at Cleveland Clinic’s Medical Innovation Summit explores lessons from the failed controlled trials of DBS for depression — and the striking reasons for continued interest in this approach.